Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

435 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Positron Emission Tomography/Computed Tomography Assessment After Immunochemotherapy and Irradiation Using the Lugano Classification Criteria in the IELSG-26 Study of Primary Mediastinal B-Cell Lymphoma.
Ceriani L, Martelli M, Gospodarowicz MK, Ricardi U, Ferreri AJ, Chiappella A, Stelitano C, Balzarotti M, Cabrera ME, Cunningham D, Guarini A, Zinzani PL, Giovanella L, Johnson PW, Zucca E. Ceriani L, et al. Among authors: johnson pw. Int J Radiat Oncol Biol Phys. 2017 Jan 1;97(1):42-49. doi: 10.1016/j.ijrobp.2016.09.031. Epub 2016 Sep 28. Int J Radiat Oncol Biol Phys. 2017. PMID: 27839910
Primary mediastinal B-cell lymphoma: high frequency of BCL-6 mutations and consistent expression of the transcription factors OCT-2, BOB.1, and PU.1 in the absence of immunoglobulins.
Pileri SA, Gaidano G, Zinzani PL, Falini B, Gaulard P, Zucca E, Pieri F, Berra E, Sabattini E, Ascani S, Piccioli M, Johnson PW, Giardini R, Pescarmona E, Novero D, Piccaluga PP, Marafioti T, Alonso MA, Cavalli F. Pileri SA, et al. Among authors: johnson pw. Am J Pathol. 2003 Jan;162(1):243-53. doi: 10.1016/s0002-9440(10)63815-1. Am J Pathol. 2003. PMID: 12507907 Free PMC article.
Primary mediastinal B-cell lymphoma.
Boleti E, Johnson PW. Boleti E, et al. Among authors: johnson pw. Hematol Oncol. 2007 Dec;25(4):157-63. doi: 10.1002/hon.818. Hematol Oncol. 2007. PMID: 17575573 Review.
Primary mediastinal large B-cell lymphoma.
Martelli M, Ferreri AJ, Johnson P. Martelli M, et al. Crit Rev Oncol Hematol. 2008 Dec;68(3):256-63. doi: 10.1016/j.critrevonc.2008.07.020. Epub 2008 Sep 7. Crit Rev Oncol Hematol. 2008. PMID: 18774728 Review.
Primary mediastinal B-cell lymphoma.
Johnson PW, Davies AJ. Johnson PW, et al. Hematology Am Soc Hematol Educ Program. 2008:349-58. doi: 10.1182/asheducation-2008.1.349. Hematology Am Soc Hematol Educ Program. 2008. PMID: 19074109 Review.
Randomized comparison of the stanford V regimen and ABVD in the treatment of advanced Hodgkin's Lymphoma: United Kingdom National Cancer Research Institute Lymphoma Group Study ISRCTN 64141244.
Hoskin PJ, Lowry L, Horwich A, Jack A, Mead B, Hancock BW, Smith P, Qian W, Patrick P, Popova B, Pettitt A, Cunningham D, Pettengell R, Sweetenham J, Linch D, Johnson PW. Hoskin PJ, et al. Among authors: johnson pw. J Clin Oncol. 2009 Nov 10;27(32):5390-6. doi: 10.1200/JCO.2009.23.3239. Epub 2009 Sep 8. J Clin Oncol. 2009. PMID: 19738111 Clinical Trial.
Hepatitis C virus and GBV-C virus prevalence among patients with B-cell lymphoma in different European regions: a case-control study of the International Extranodal Lymphoma Study Group.
Nicolosi Guidicelli S, Lopez-Guillermo A, Falcone U, Conconi A, Christinat A, Rodriguez-Abreu D, Grisanti S, Lobetti-Bodoni C, Piffaretti JC, Johnson PW, Mombelli G, Cerny A, Montserrat E, Cavalli F, Zucca E. Nicolosi Guidicelli S, et al. Among authors: johnson pw. Hematol Oncol. 2012 Sep;30(3):137-42. doi: 10.1002/hon.1015. Epub 2011 Nov 21. Hematol Oncol. 2012. PMID: 22105737
Addition of rituximab to chlorambucil produces superior event-free survival in the treatment of patients with extranodal marginal-zone B-cell lymphoma: 5-year analysis of the IELSG-19 Randomized Study.
Zucca E, Conconi A, Laszlo D, López-Guillermo A, Bouabdallah R, Coiffier B, Sebban C, Jardin F, Vitolo U, Morschhauser F, Pileri SA, Copie-Bergman C, Campo E, Jack A, Floriani I, Johnson P, Martelli M, Cavalli F, Martinelli G, Thieblemont C. Zucca E, et al. J Clin Oncol. 2013 Feb 10;31(5):565-72. doi: 10.1200/JCO.2011.40.6272. Epub 2013 Jan 7. J Clin Oncol. 2013. PMID: 23295789 Clinical Trial.
Rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone in patients with newly diagnosed diffuse large B-cell non-Hodgkin lymphoma: a phase 3 comparison of dose intensification with 14-day versus 21-day cycles.
Cunningham D, Hawkes EA, Jack A, Qian W, Smith P, Mouncey P, Pocock C, Ardeshna KM, Radford JA, McMillan A, Davies J, Turner D, Kruger A, Johnson P, Gambell J, Linch D. Cunningham D, et al. Lancet. 2013 May 25;381(9880):1817-26. doi: 10.1016/S0140-6736(13)60313-X. Epub 2013 Apr 22. Lancet. 2013. PMID: 23615461 Free article. Clinical Trial.
Treatment for patients with indolent and mantle cell lymphoma.
Zucca E, Thieblemont C, Martinelli G, Johnson PW, Cavalli F. Zucca E, et al. Among authors: johnson pw. Lancet. 2013 Sep 28;382(9898):1094. doi: 10.1016/S0140-6736(13)62017-6. Lancet. 2013. PMID: 24075045 No abstract available.
435 results